Product Name |
MF |
CAS |
Details |
1-(6-Methoxynaphthalen-2-yl)ethanol |
C13H14O2 |
77301-42-9 |
|
2,2,2-trichloroacetamidine |
C2H3Cl3N2 |
2533-68-8 |
|
Gardenin |
C21H22O9 |
21187-73-5 |
|
3-Methyl-4-nitropyridine |
C6H6N2O3 |
1074-98-2 |
|
Potassium 2,5-dihydroxybenzenesulfonate |
C6H7KO5S |
21799-87-1 |
|
Epoxyazadiradione |
C28H34O6 |
18385-59-6 |
|
Lidocaine |
C14H22N2O |
137-58-6 |
|
2’, 4’, 6’-Trimethoxyacetophenone |
C11H14O4 |
832-58-6 |
|
(E)-2-(1-(((1-(3-(2-(7-chloroquinolin-2-yl)vinyl)phenyl)-3- (2-(2-hydroxypropan-2-yl)phenyl)propyl)sulfinyl)methyl) cyclopropyl) acetic acid |
C35H36ClNO4S |
909849-96-3 |
|
4-Amino-2-nitrophenol |
C6H6N2O3 |
119-34-6 |
|
6-Bromo Chromon-2-Carboxylic Acid |
C10H5BrO4 |
51484-06-1 |
|
cis-5-[(2RS)-2-Hydroxy-3-methoxypropoxy]-1,2,3,4- tetrahydronaphtalene-2,3-diol (Nadolol EP Impurity B) |
C14H20O5 |
2714744-89-3 |
|
Methyl 7-[(1R,2S)-2-[(E)-4-hydroxy-4-methyloct-1-enyl]- 5-oxocyclopent-3-en-1-yl]heptanoate |
C22H36O4 |
58682-86-3 |
|
(S)-(+)-Turmerone,Ar |
C15H20O |
532-65-0 |
|
6-methyl-quinoline |
C10H9N |
91-62-3 |
|
2,2-Dimethylglutaric anhydride |
C7H10O3 |
2938-48-9 |
|
7-Azido-4-methylcoumarin |
C10H7N3O2 |
95633-27-5 |
|
Etone Amine |
C15H23NO2 |
26218-04-2 |
|
2,3-Dihydrobenzo[b][1,4]dioxine |
C8H8O2 |
493-09-4 |
|
3-Dimethylaminopropiophenone hydrochloride |
C11H16ClNO |
879-72-1 |
|
Coumarin 334 |
C17H17NO3 |
55804-67-6 |
|
(11Z)-(3-(Dimethyl amino) propylidene)-6, 11- dihydrodibenzo [b, e] oxepin-2-N, N- dimethylacetamide; (11Z)-11-[3-(dimethylamino) propylidene]-6,11-dihydro-N,N-dimethyl-Dibenz[b,e] oxepin-2-acetamide; (Olopatadine amide impurity (Z-isomer)) |
C23H28N2O2 |
872041-02-6 |
|
Ribociclib impurity-13 |
|
|
|
Dutasteride / Finasteride impurity |
C19H29NO3 |
103335-55-3 |
|
2-Bromo-1-(4-chlorophenyl)propan-1-one |
C9H8BrClO |
877-37-2 |
|
Diazoxide impurity-6 (2-Amino-5-chlorobenzenesulfonamide) |
C6H7ClN2O2S |
5790-69-2 |
|
2-(3,4-Dimethoxyphenyl)-2-Isopropyl-3-Methylbutanenitrile |
C16H23NO2 |
51698-54-5 |
|
(4R,12aS)-N-(2,6-Difluorobenzyl)-7-hydroxy-4-methyl- 6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H- pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide |
C20H19F2N3O5 |
2244161-72-4 |
|
Zanubrutinib impurity-2; Chloropropanoyl Zanubrutinib impurity; ((S)-7-(1-(3-Chloropropanoyl)piperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide) |
C27H30ClN5O3 |
1633351-79-7 |
|
3-Acetyl-6-bromocoumarin |
C11H7BrO3 |
2199-93-1 |
|
5-Bromopyrimidine |
C4H3BrN2 |
4595-59-9 |
|
6-bromo-2,2-dimethyl-4-p-tolyl-2H-chromene |
C18H17BrO |
204449-20-7 |
|
ethyl (2-fluoro-4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)carbamate |
C16H16FN3O4 |
2514957-39-0 |
|
(S)-5-Bromo-6-methoxy-α-methyl-2-naphthaleneacetic Acid |
C14H13BrO3 |
84236-26-0 |
|
4,5-bis-(Chloromethyl)-1,3-dioxolan-2-one |
C5H6Cl2O3 |
1487-64-5 |
|
Zanubrutinib impurity-4; (Pyrazolo[1,5-a]pyrimidine-3-carbonitrile, 4,5,6,7-tetrahydro-2-(4-phenoxyphenyl)-7-(4-piperidinyl)-) |
C24H25N5O |
2190506-57-9 |
|
2,6-Dichloroquinoxaline |
C8H4Cl2N2 |
18671-97-1 |
|
NBD-amine |
C6H4N4O3 |
10199-91-4 |
|
4-ACETAMIDO BENZENE SULPHONYLAZIDE |
C8H8N4O3S |
2158-14-7 |
|
2-Amino-3-Nitro benzoic acid |
C7H6N2O4 |
606-18-8 |
|
4-Hydroxy-3- nitrocoumarin |
C9H5NO5 |
20261-31-8 |
|
2-Phenylbutanoic acid |
C10H12O2 |
90-27-7 |
|
2-Amino-4,6-dichloropyrimidine-5-carbaldehyde |
C5H3Cl2N3O |
5604-46-6 |
|
(Ethoxycarbonylmethyl)triphenylphosphonium bromide |
C22H22BrO2P |
1530-45-6 |
|
Sodium cyano borohydride |
CH3BNNa |
25895-60-7 |
|
1,2-diethylbenzene |
C10H14 |
135-01-3 |
|
2-cis,4-trans-Abscisic acid |
C15H20O4 |
14375-45-2 |
|
Coumarin 343 |
C16H15NO4 |
55804-65-4 |
|
4-Cyano-2-methoxybenzaldehyde |
C9H7NO2 |
21962-45-8 |
|
3,6-Dichloro-1,2-benzenedithiol |
C6H4Cl2S2 |
87314-49-6 |
|
2-Bromo-1-(2-hydroxy-5-methylphenyl)ethanone |
C9H9BrO2 |
51317-87-4 |
|
1-(2-acetamidoethyl)naphthalen-7-yl acetate (Agomelatine) |
C15H17NO2 |
138112-76-2 |
|
Withanolide A |
C28H38O6 |
32911-62-9 |
|
(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butan-1-amine |
C16H26N2 |
147769-93-5 |
|
2-(1-Cyanocyclohexyl) acetic acid |
C9H13NO2 |
133481-09-1 |
|
4-(Benzyloxy)benzene-1,2-diamine |
C13H14N2O |
41927-17-7 |
|
2-Methyl-6-nitroaniline |
C7H8N2O2 |
570-24-1 |
|
1-Methoxy-4-oxocyclohexane-1-carboxylic acid |
C8H12O4 |
1622928-68-0 |
|
7-Chloro-1-indanone |
C9H7ClO |
34911-25-6 |
|
BICINE or N,N-bis(2-hydroxyethyl)glycine |
C6H13NO4 |
150-25-4 |
|
2,3,5-Trichlorobenzaldehyde |
C7H3Cl3O |
56961-75-2 |
|
Methyl N [5-(propane-2-yl)sulfanyl]-1H-benzimidazol-2- yl] carbamate |
C12H15N3O2S |
108579-67-5 |
|
4-chloro-3-(chlorosulfonyl)-5-nitrobenzoic acid |
C7H3Cl2NO6S |
22892-95-1 |
|
1-Azabicyclo[2.2.2]octan-3-yl 2-hydroxy-2,2- diphenylacetate |
C21H23NO3 |
62869-69-6 |
|
1,6-dichloroisoquinoline |
C9H5Cl2N |
630421-73-7 |
|
4-(Difluoromethoxy)phenol |
C7H6F2O2 |
87789-47-7 |
|
(R)-4-propyldihydrofuran-2(3H)-one |
C7H12O2 |
63095-51-2 |
|
(6aS,7S,9aR)-N-(2,5-Bis(Trifluoromethyl)phenyl)-6a- methyl-2-oxo-2,5,6,6a,7,8,9,9a-octahydro-1H- indeno[5,4-f]quinoline-7-carboxamide |
C26H22F6N2O2 |
952718-75-1 |
|
(3S,4S)-1-(4-Fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3- hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one |
C24H21F2NO3 |
1593543-07-7 |
|
5,7-Dichloro-3-Methyl-2H-1,2,4-Benzothiadiazine-1,1-Dioxide (Diazoxide impurity) |
C8H6Cl2N2O2S |
6059-27-4 |
|
Diazoxide impurity-3 (N-((2-aminophenyl)sulfonyl)acetamide; 6-Chloro diazoxide) |
C8H10N2O3S |
75304-18-6 |
|
2-Chloro-1-(trifluoromethyl)-3-isocyanatobenzene |
C8H3ClF3NO |
88330-63-6 |
|
4-(nitrooxy)butyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2- ((R)-3-hydroxy-5-phenylpentyl)cyclopentyl)hept-5- enoate |
C27H41NO8 |
860005-21-6 |
|
(3E,5E)-octa-3,5-dien-2-one |
C8H12O |
4173-41-5 |
|
Ethyl 2,4-dichloro-3-hydroxybenzoate |
C9H8Cl2O3 |
129788-29-0 |
|
Sinapinic acid |
C11H12O5 |
530-59-6 |
|
2-Amino-2-(hydroxymethyl)propane-1,3-diol |
C4H11NO3 |
77-86-1 |
|
(2R,3R,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H- pyran-3,4,5-triol |
C21H25ClO6 |
1373321-04-0 |
|
(Z)-N,6,6-Trimethyl-N-(naphthalen-2-ylmethyl)hept-2- en-4-yn-1-amine |
C21H25N |
926281-74-5 (Free base) |
|
(E)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(E)-(3S)-3- hydroxy-3-methyloct-1-enyl]cyclopentyl]-5-heptenoic acid |
C21H36O5 |
76498-29-8 |
|
O-Benzylhydroxylamine hydrochloride |
C7H10ClNO |
2687-43-6 |
|
1-(9H-Carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy) ethyl amino] propan-2-ol |
C24H26N2O4 |
72956-09-3 |
|
Harmol Hydrochloride |
C12H11ClN2O |
40580-83-4 |
|
8-Chloro-1,5-dihydro-3-methylimidazo[1,2-a]pyrazine |
C7H6ClN3 |
56468-24-7 |
|
4-(1,3-Dioxolan-2-yl)phenylmagnesium bromide |
C9H9BrMgO2 |
328000-17-5 |
|
Coumarin 540A |
C16H14F3NO2 |
53518-18-6 |
|
tert-butyl 4-methylenepiperidine-1-carboxylate |
C11H19NO2 |
159635-49-1 |
|
4-Hydroxy-3-methylbenzaldehyde |
C8H8O2 |
15174-69-3 |
|
3-Amino-5-bromo pyridine |
C5H5BrN2 |
13535-01-8 |
|
Diazoxide impurity-4 (7-chloro-3-methyl-2H-1,2,4-benzothiadiazine 1,1-dioxide) |
C8H7ClN2O2S |
364-98-7 |
|
Methyl 2-hydroxy-2,2-diphenylacetate |
C15H14O3 |
76-89-1 |
|
6-chloro-5-methoxypyrimidin-4-amine |
C5H6ClN3O |
5018-41-7 |
|
4-Bromobenzenesulphonyl chloride |
C6H4BrClO2S |
98-58-8 |
|
4-Nitrophenyl) hexadecanoate |
C22H35NO4 |
1492-30-4 |
|
Guggulsterone-E |
C21H28O2 |
39025-24-6 |
|
3-((3-(N-(Isopropylcarbamoyl)sulfamoyl)pyridin-4-yl)amino)benzoic Acid; (Torasemide carboxylic acid; Torasemide M5) |
C16H18N4O5S |
113844-99-8 |
|
EMPA intermediate |
C17H14BrClO3 |
915095-84-0 |
|
4-[[5-[[(Cyclopentyloxy)carbonyl]amino]-1-methyl-1H- indol-3-yl]methyl]-3-methoxy-benzoic Acid Methyl Ester |
C25H28N2O5 |
107754-19-8 |
|
methyl 3-cyanobenzoate |
C9H7NO2 |
13531-48-1 |
|
Tris(2-carboxyethyl)phosphine hydrochloride, |
C9H15O6P.ClH |
51805-45-9 |
|